US Next in Line for Minimally Invasive Fistula Creation System
Avenu’s Ellypsys Vascular Acess System uses a catheter guided through a blood vessel to create a dialysis fistula by fusing vessels together with heat. There is no foreign material (even stitches). CE-MARK approved in Europe, and a Phase III trial in the U.S. is underway.
Read the full article » | Posted 06-08-2016
Related Articles
- Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
- AWAK PD To Go Posted 10-05-2026
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026

